Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Biliary Tract Cancer × sitravatinib × Gastrointestinal × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3 Esophageal Squamous Cell Carcinoma 1 Carcinoma 1 Advanced Biliary Tract Cancer 1

Interventions

lenvatinib 3 durvalumab 3 Gemcitabine 3 Cisplatin 3 tislelizumab 2 sintilimab 2 pembrolizumab 2 toripalimab 1 theasinensin A 1 surufatinib 1 sitravatinib 1 regorafenib 1 S 1 (combination) 1 Injections 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727996 2024-04-19

BTC-BGB

Seoul National University Hospital

Phase 2 Active not recruiting

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡